These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 21070930

  • 1. Between a rock and a hard place.
    Demaria AN.
    J Am Coll Cardiol; 2010 Nov 16; 56(21):1761-2. PubMed ID: 21070930
    [No Abstract] [Full Text] [Related]

  • 2. Advances in cardiovascular pharmacology: protocol design and methodology--the US regulatory process.
    Somberg JC, Borer JS.
    Am J Ther; 1999 May 16; 6(3):175-8. PubMed ID: 10423661
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drug-development process already subject to oversight.
    Sipkoff M.
    Manag Care; 2005 Jan 16; 14(1):78, 80-1. PubMed ID: 15742757
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The FDA is no place for politics.
    Nat Struct Mol Biol; 2006 May 16; 13(5):379. PubMed ID: 16738601
    [No Abstract] [Full Text] [Related]

  • 8. Impact of new regulations for pediatric labeling by the Food and Drug Administration.
    Buck ML.
    Pediatr Nurs; 2000 May 16; 26(1):95-6. PubMed ID: 12026326
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Indian company seeks US approval for generic AIDS drugs.
    Nature; 2004 Aug 12; 430(7001):716. PubMed ID: 15306779
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Will FDA relinquish the "gold standard" for new drug approval? Redefining "substantial evidence" in the FDA Modernization Act of 1997.
    Kulynych J.
    Food Drug Law J; 1999 Aug 12; 54(1):127-49. PubMed ID: 11758555
    [No Abstract] [Full Text] [Related]

  • 14. The Food and Drug Administration and patent law at a crossroads: the listing of polymorph patents as a barrier to generic drug entry.
    Srivastava D.
    Food Drug Law J; 2004 Aug 12; 59(2):339-54. PubMed ID: 15298015
    [No Abstract] [Full Text] [Related]

  • 15. An uncertain future for cardiovascular drug development?
    Garber AM.
    N Engl J Med; 2009 Mar 19; 360(12):1169-71. PubMed ID: 19297568
    [No Abstract] [Full Text] [Related]

  • 16. Off-label drug use.
    Dooley AG.
    Med Health R I; 2007 Feb 19; 90(2):63-5. PubMed ID: 17500258
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.